COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

Posted by Written by Dezan Shira & Associates Reading Time: 14 minutes

(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on September 22, 2021)

Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.

Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.

For specific updates concerning China and related business advisory, please click here.

Please refresh the page to get the latest updates.

ASEAN coronavirus updates (Live updates by country)

Brunei

Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.   

  • Brunei reported 124 new cases and one death on September 21, taking the totals to 5,385 cases and 29 deaths.
  • Brunei recorded 214 new cases and two deaths on September 20, bringing the tallies to 5,261 cases and 28 deaths.
  • Brunei saw 90 new cases on September 19, taking the total to 5,047 cases amid 26 deaths.

Cambodia

Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.  

  • Cambodia recorded 637 new cases and 14 deaths on September 22, taking the tallies to 105,981 cases and 2,154 deaths.
  • Cambodia saw 628 new cases and 17 deaths on September 21, bringing the totals to 105,344 cases and 2,140 deaths.
  • Cambodia reported 622 new cases and 14 deaths on September 20, taking the tallies to 104,716 cases and 2,123 deaths.

Indonesia

Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 270 million. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population. 

  • Indonesia saw 2,720 new cases and 149 deaths on September 22, taking the totals to 4,198,678 cases and 140,954 deaths.
  • Indonesia recorded 3,263 new cases and 171 deaths on September 21, bringing the tallies to 4,195,958 cases and 140,805 deaths.
  • Indonesia reported 1,932 new cases and 166 deaths on September 20, taking the totals to 4,192,695 cases and 140,634 deaths.

Laos

Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.  

  • Laos recorded 331 new cases on September 21, taking the total to 19,730 cases amid 16 deaths.
  • Laos saw 214 new cases on September 20, bringing the total to 19,399 cases amid 16 deaths.
  • Laos reported 371 new cases on September 19, taking the total to 19,185 cases amid 16 deaths.

Malaysia

Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens. 

  • Malaysia saw 15,759 new cases and 334 deaths on September 21, bringing the totals to 2,127,934 cases and 24,078 deaths.
  • Malaysia recorded 14,345 new cases and 301 deaths on September 20, taking the tallies to 2,112,175 cases and 23,744 deaths.
  • Malaysia reported 14,954 new cases and 376 deaths on September 19, bringing the totals to 2,097,830 cases and 23,443 deaths.

Myanmar

Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.   

  • Myanmar saw 1,687 new cases and 73 deaths on September 21, bringing the totals to 449,845 cases and 17,202 deaths.
  • Myanmar reported 1,585 new cases and 56 deaths on September 20, taking the tallies to 448,158 cases and 17,129 deaths.
  • Myanmar saw 1,702 new cases and 57 deaths on September 19, taking the totals to 446,573 cases and 17,073 deaths.

Philippines

The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees. 

  • The Philippines recorded 15,592 new cases and 154 deaths on September 22, taking the tallies to 2,417,419 cases and 37,228 deaths.
  • The Philippines reported 16,361 new cases and 140 deaths on September 21, bringing the totals to 2,401,916 cases and 37,074 deaths.
  • The Philippines saw 18,937 new cases and 146 deaths on September 20, taking the tallies to 2,385,616 cases and 36,934 deaths.

Singapore

Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.     

  • Singapore reported 617 new cases and two deaths on September 20, taking the total to 78,721 cases and 62 deaths.
  • Singapore saw 1,012 new cases on September 19, taking the total to 77,804 cases amid 60 deaths.
  • Singapore recorded 1,009 new cases and one death on September 18, taking the tallies to 76,792 cases and 60 deaths.

Thailand

Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.   

  • Thailand reported 11,252 new cases and 141 deaths on September 22, bringing the totals to 1,511,357 cases and 15,753 deaths.
  • Thailand recorded 10,919 new cases and 143 deaths on September 21, taking the tallies to 1,500,105 cases and 15,612 deaths.
  • Thailand saw 12,709 new cases and 106 deaths on September 20, bringing the totals to 1,489,186 cases and 15,469 deaths.

Vietnam

Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.  

Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.

  • As of September 22, 2021, Vietnam’s Ministry of Health confirmed a total of 707,436 cases of COVID-19. However, 475,343 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 17,545 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Binh Duong, Dong Nai, Long An, and Kien Giang among others.
  • As of September 21, 2021, Vietnam’s Ministry of Health confirmed a total of 695,744 cases of COVID-19. However, 464,326 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 17,305 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Binh Duong, Dong Nai, Long An, and Tien Giang among others.
  • As of September 20, 2021, Vietnam’s Ministry of Health confirmed a total of 707,436 cases of COVID-19. However, 457,505 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 17,545 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Binh Duong, Dong Nai, An Giang, and Long An among others.

Other Asian countries and Regions

Afghanistan

Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either. 

  • As of September 22, Afghanistan has 154,800 cases and 7,194 deaths.
  • Afghanistan has 154,756 cases and 7,193 deaths as of September 21.
  • As of September 20, Afghanistan has 154,712 cases and 7,199 deaths.

Bangladesh

Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.     

  • Bangladesh has 1,547,176 cases and 27,313 deaths as of September 22.
  • Bangladesh has 1,545,800 cases and 27,277 deaths as of September 21.
  • As of September 20, Bangladesh has 1,544,238 cases and 27,251 deaths.

Bahrain

Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.  

  • Bahrain has 274,452 cases and 1,388 deaths as of September 21.
  • As of September 20, Bahrain has 274,383 cases and 1,388 deaths.
  • Bahrain has 274,264 cases and 1,388 deaths as of September 19.

China

For specific updates concerning China, please click here.

For a complete overview of China’s vaccine availability please go here.

  • China reported 41 new cases on September 22, taking the total to 95,851.
  • China recorded 72 new cases on September 21, bringing the total to 95,810.
  • China saw 49 new cases on September 20, taking the total to 95,738.

East Timor

East Timor is receiving assistance from the Gavi Institute.  

  • East Timor has 19,206 cases and 108 deaths as of September 22.
  • As of September 21, East Timor has 19,125 cases and 107 deaths.
  • East Timor has 19,058 cases and 105 deaths as of September 20.

Hong Kong

Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.  

  • Hong Kong has 12,168 cases and 213 deaths as of September 22.
  • Hong Kong has 12,167 cases and 213 deaths as of September 21.
  • As of September 20, Hong Kong has 12,166 cases and 213 deaths.

India

For a complete overview of India’s vaccine availability please go here.

  • India has 33,530,077 cases and 445,801 deaths as of September 21.
  • As of September 20, India has 33,502,744 cases and 445,416 deaths.
  • Our new India-specific updates can be found here.

Iran

Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.   

  • Iran has 5,477,229 cases and 118,191 deaths as of September 22.
  • As of September 21, Iran has 5,459,796 cases and 117,905 deaths.
  • Iran has 5,442,232 cases and 117,526 deaths as of September 20.

Iraq

Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021. 

  • Iraq has 1,981,493 cases and 21,911 deaths as of September 21.
  • As of September 20, Iraq has 1,978,412 cases and 21,869 deaths.
  • Iraq has 1,975,220 cases and 21,822 deaths as of September 19.

Japan

Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021. 

  • As of September 22, Japan has 1,681,120 cases and 17,276 deaths.
  • Japan has 1,679,116 cases and 17,233 deaths as of September 21.
  • As of September 20, Japan has 1,676,711 cases and 17,204 deaths.

Jordan

Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021. 

  • Jordan has 815,546 cases and 10,633 deaths as of September 21.
  • Jordan has 814,676 cases and 10,624 deaths as of September 20.
  • As of September 19, Jordan has 813,601 cases and 10,616 deaths.

Kazakhstan

Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.  

  • As of September 22, Kazakhstan has 867,366 cases and 10,860 deaths.
  • Kazakhstan has 864,955 cases and 10,810 deaths as of September 21.
  • As of September 20, Kazakhstan has 862,862 cases and 10,763 deaths.

Kuwait

All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.

  • Kuwait has 411,278 cases and 2,441 deaths as of September 21.
  • Kuwait has 411,233 cases and 2,440 deaths as of September 20.
  • As of September 19, Kuwait has 411,180 cases and 2,439 deaths.

Kyrgyzstan

Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021. 

  • As of September 22, Kyrgyzstan has 177,941 cases and 2,595 deaths.
  • Kyrgyzstan has 177,869 cases and 2,592 deaths as of September 21.
  • As of September 20, Kyrgyzstan has 177,780 cases and 2,590 deaths.

Lebanon

Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.  

  • As of September 21, Lebanon has 619,232 cases and 8,246 deahs.
  • Lebanon has 618,580 cases and 8,240 deaths as of September 20.
  • Lebanon has 618,278 cases and 8,236 deaths as of September 19.

Macao

Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.   

  • As of August 4, Macau has 63 cases.
  • Macau has 59 cases as of July 25.
  • As of July 24, Macau has 58 cases.

Maldives

The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.  

  • The Maldives has 83,875 cases and 229 deaths as of September 1.
  • As of September 20, the Maldives has 83,655 cases and 229 deaths. 
  • The Maldives has 83,576 cases and 229 deaths as of September 19.

Mongolia

Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021. 

  • As of September 22, Mongolia has 283,956 cases and 1,146 deaths.
  • Mongolia has 280,540 cases and 1,132 deaths as of September 21.
  • As of September 20, Mongolia has 277,997 cases and 1,119 deaths.

Nepal

Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.  

  • Nepal has 787,828 cases and 11,059 deaths as of September 22.
  • Nepal has 786,577 cases and 11,053 deaths as of September 21.
  • As of September 20, Nepal has 785,541 cases and 11,048 deaths.

North Korea

North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.  

  • North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.

Oman

Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).    

  • As of September 22, Oman has 303,512 cases and 4,093 deaths.
  • Oman has 303,490 cases and 4,093 deaths as of September 21.
  • Oman has 303,459 cases and 4,093 deaths as of September 20.

Pakistan

Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021. 

  • As of September 22, Pakistan has 1,230,238 cases and 27,374 deaths.
  • Pakistan has 1,227,905 cases and 27,327 deaths as of September 21.
  • As of September 20, Pakistan has 1,226,008 cases and 27,246 deaths.

Palestine

Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.   

  • Palestine has 388,470 cases and 3,952 deaths as of September 21.
  • Palestine has 386,493 cases and 3,935 deaths as of September 20.
  • As of September 19, Palestine has 384,390 cases and 3,919 deaths.

Qatar

Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021. 

  • Qatar has 235,769 cases and 604 deaths as of September 21.
  • As of September 20, Qatar has 235,626 cases and 604 deaths.
  • Qatar has 235,487 cases and 604 deaths as of September 19.

Russia

A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.

  • As of September 22, Russia has 7,333,557 cases and 200,625 deaths.
  • Russia has 7,313,851 cases and 199,808 deaths as of September 21.
  • Our new Russia-specific updates here.

Saudi Arabia

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021. 

  • As of September 22, Saudi Arabia has 546,735 cases and 8,679 deaths.
  • Saudi Arabia has 546,681 cases and 8,672 deaths as of September 21.
  • Saudi Arabia has 546,612 cases and 8,667 deaths as of September 20.

South Korea

South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021. 

  • South Korea has 290,983 cases and 2,419 deaths as of September 22.
  • As of September 21, South Korea has 289,263 cases and 2,413 deaths.
  • South Korea has 287,536 cases and 2,409 deaths as of September 20.

Sri Lanka

Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.    

  • Sri Lanka has 507,330 cases and 12,284 deaths as of September 21.
  • As of September 20, Sri Lanka has 506,009 cases and 12,218 deaths.
  • Sri Lanka has 504,491 cases and 12,125 deaths as of September 19.

Taiwan

Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.  

  • As of September 22, Taiwan has 16,159 cases and 841 deaths.
  • Taiwan has 16,152 cases and 840 deaths as of September 21.
  • As of September 20, Taiwan has 16,147 cases and 840 deaths.

Turkey

Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.   

  • Turkey has 6,904,285 cases and 62,065 deaths as of September 21.
  • Turkey has 6,874,947 cases and 61,805 deaths as of September 20.
  • As of September 19, Turkey has 6,847,259 cases and 61,574 deaths.

United Arab Emirates

The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates.  The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.  

  • The UAE has 733,325 cases and 2,078 deaths as of September 21.
  • The UAE has 733,003 cases and 2,077 deaths as of September 20.
  • As of September 19, the UAE has 732,690 cases and 2,075 deaths.

Uzbekistan

Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021. 

  • Uzbekistan has 169,467 cases and 1,197 deaths as of September 21.
  • Uzbekistan has 168,938 cases and 1,192 deaths as of September 20.
  • As of September 19, Uzbekistan has 168,437 cases and 1,188 deaths.

Yemen

Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.   

  • Yemen has 8,752 cases and 1,654 deaths as of September 21.
  • Yemen has 8,718 cases and 1,649 deaths as of September 20.
  • As of September 19, Yemen has 8,667 cases and 1,643 deaths.

Related Reading


About Us

ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in SingaporeHanoiHo Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, Milan, Conegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at asia@dezshira.com or visit our website at www.dezshira.com.